MicroBiome Therapeutics Completes Series B Financing and Prepares to Launch First Microbiome Modulator Product NEW ORLEANS, La., Nov. 01, 2017 (GLOBE NEWSWIRE) -- MicroBiome Therapeutics, LLC (MBT), a leading company applying the science of the gastrointestinal (GI) microbiome to promote health and wellness,...